CNO California Nanotechnologies Corp.
California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction in the United States. The company offers sintering, bonding, and hot isostatic pressing services, including spark plasma/field assisted sintering, hot pressing/direct hot pressing, high temp sintering, diffusion bonding, and vacuum/pressure-less sintering; cryo milling/particle reduction/grinding comprising cryogenic milling and grinding, planetary ball milling, mechanical alloying, inert gas milling, and pulverizing services; and material development/testing, such as composites/nano-composites, mechanical testing and analysis, sample fabrication, prototyping, SEM analysis, and particle size analysis, as well as coating targets/sputter targets. It also provides nuclear materials and reactor components, such as boron carbide, advanced ceramics, and refractory alloys manufactured using spark plasma sintering and advanced powder processing; engineered materials for design; and materials synthesis and model validation services. In addition, the company offers tooling and consumables, which consists of high strength SPS graphite tooling, tungsten carbide tooling, carbon graphite foil/paper, and carbon felt and yarn, as well as spark plasma sintering systems and SPS/FAST modeling software. It serves defense and aerospace, energy and nuclear, electronics and semiconductors, sustainable technologies, and research and development industries. California Nanotechnologies Corp. is headquartered in Cerritos, California.…
Industry Peers
Metal FabricationKey Statistics
About California Nanotechnologies (CVE: CNO)
›
California Nanotechnologies (CVE: CNO) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Metal Fabrication industry, part of the Industrials sector, and reports about 20 employees.
The shares were at 0.3550 CAD on 19 November 2026, down 11.3% over 52 weeks. Its 52-week range is 0.1800 CAD to 0.4700 CAD: the price is 24.5% below the high and 97.2% above the low.
Its market capitalisation is 18.98M CAD.
California Nanotechnologies reports return on equity of -93.9%, an operating margin of -66.2% and revenue up 22.7% year over year.
Its debt exceeds its cash by 806.31K USD, a debt-to-equity ratio of 0.66. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 0.7655 CAD is 115.6% above the current price. The next earnings report is expected on 28 January 2027.